Apolipoprotein E deletion has no effect on copper-induced oxidative stress in the mice brain

Biosci Rep. 2018 Sep 7;38(5):BSR20180719. doi: 10.1042/BSR20180719. Print 2018 Oct 31.

Abstract

The current study was designed to investigate effect of copper administration on oxidative damage to the brain in ApoE-/- mice and to explore the putative neuroprotective effects rendered by apolipoprotein E (ApoE). Male C57BL/6 ApoE-/- and wild-type mice were randomly assigned into four groups, ApoE-/- mice wild-type mice treated with either copper or saline. Copper sulphate pentahydrate or saline (200 µl) were administered intragastrically daily for 12 weeks. Expression of malondialdehyde, superoxide dismutase (SOD), hemeoxygenase 1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1) were determined by a combination of biochemical assays. The concentration of copper in the brain of C57BL/6 mice and ApoE-/- mice treated by copper significantly increased compared with mice treated by saline (P=0.0099 and P=0.0443). Compared with the C57BL/6 mice treated by copper, the level of the ApoE-/- mice treated by copper was higher (P=0.018). TBARS and SOD activities or the expressions of NQO1 and HO-1 in the brain were not significantly different amongst the four experimental groups of mice. The relative value of NQO1/β-actin expression in the brain of the ApoE-/- mice was similar in both saline and copper administration experimental groups. However, Western blot analysis showed that NQO1 expression was significantly higher in the ApoE-/- mice brain treated with saline compared with saline treated wild-type mice (P=0.0449). ApoE does not function in protecting the brain from oxidative damage resulting from copper build-up in Wilson's disease, but may play a role in regulating copper accumulation in the brain.

Keywords: ApoE knockout mice; Wilson’s disease; copper buildup; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins E / genetics*
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Copper / administration & dosage
  • Gene Expression Regulation / drug effects
  • Heme Oxygenase-1 / genetics
  • Hepatolenticular Degeneration / genetics*
  • Hepatolenticular Degeneration / pathology
  • Hepatolenticular Degeneration / prevention & control
  • Humans
  • Mice
  • Mice, Knockout
  • NAD(P)H Dehydrogenase (Quinone) / genetics
  • Neuroprotective Agents / metabolism
  • Oxidative Stress / drug effects*
  • Oxidative Stress / genetics
  • Sequence Deletion / genetics
  • Superoxide Dismutase / genetics

Substances

  • Apolipoproteins E
  • Neuroprotective Agents
  • Copper
  • Heme Oxygenase-1
  • Superoxide Dismutase
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human